Ken Griffin Olink Holding Ab (Publ) Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$21.81 - $25.14 $2.3 Million - $2.65 Million	-105,307 Reduced 97.36%	2,860 $67,000
Q4 2023 Feb 14, 2024	BUY	$14.29 - $25.95 $1.13 Million - $2.05 Million	78,902 Added 269.61%	108,167 $2.72 Million
Q3 2023 Nov 14, 2023	BUY	$14.45 - $20.34 $417,330 - $587,439	28,881 Added 7521.09%	29,265 $431,000
Q2 2023 Aug 14, 2023	SELL	$17.13 - $23.74 $156,842 - $217,363	-9,156 Reduced 95.97%	384 $7,000
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $179,803 - $224,150	9,297 Added 3825.93%	9,540 $214,000
Q4 2022 Feb 14, 2023	SELL	$12.64 - $25.52 $264,441 - $533,903	-20,921 Reduced 98.85%	243 $6,000
Q3 2022 Nov 14, 2022	SELL	$12.14 - $18.42 $684,708 - $1.04 Million	-56,401 Reduced 72.71%	21,164 $257,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.